GLP1 Agonists Reduce Major Adverse Liver Outcomes in Chronic Liver Disease
MONDAY, Jan. 29, 2024 (HealthDay News) -- For patients with chronic liver disease and type 2 diabetes, glucagon-like peptide-1 receptor (GLP1) agonists may result in a lower risk for major ...